Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for lung cancer surgery equipment has been experiencing strong growth recently, driven by advances in technology and an increasing number of lung cancer cases worldwide. As medical procedures evolve and more specialized treatment centers emerge, this sector is set to expand further in the coming years. Here is a detailed overview of the market size, key growth factors, trends, major players, and regional dynamics shaping this industry.

Projected Growth and Market Size of the Lung Cancer Surgery Equipment Market

The lung cancer surgery equipment market has shown significant growth and is poised to continue this trajectory. It is expected to increase from $3.73 billion in 2025 to $3.98 billion in 2026, marking a compound annual growth rate (CAGR) of 6.7%. This historical growth phase was largely driven by the limited availability of advanced thoracic surgery equipment, continued reliance on traditional open surgeries, a rising incidence of lung cancer, expansion in the number of hospitals and surgical clinics, and widespread adoption of standard biopsy and imaging techniques. Looking ahead, the market is forecasted to reach $5.1 billion by 2030, growing at a CAGR of 6.4%. This surge is attributed to the development of robotic-assisted and minimally invasive surgical tools, the integration of AI-enabled imaging and monitoring systems, increased funding for research and academic institutions, growing use of enhanced recovery after surgery (ERAS) protocols, and the expansion of specialized lung cancer treatment centers. Key trends expected in this period include the rise of minimally invasive lung surgeries, greater demand for advanced diagnostic and imaging equipment, integration of patient monitoring with surgical devices, heightened focus on postoperative care, and the growth of robotic-assisted thoracic surgery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

Factors Contributing to Demand in the Lung Cancer Surgery Equipment Market

One of the primary drivers of growth in this market is the increasing prevalence of lung cancer globally. Lung cancer arises when abnormal cells multiply uncontrollably in the lungs, typically linked to smoking and harmful environmental exposures. Rising cases are connected to factors such as tobacco smoke, air pollution, occupational carcinogens, and an aging population. Lung cancer surgery equipment plays a vital role in diagnosing the disease, surgically removing cancerous tissue, and supporting postoperative care through precise surgical and monitoring technologies. For example, in February 2025, the Cancer Council of Australia reported that approximately 15,122 people were diagnosed with lung cancer in 2024, with the average age at diagnosis being 72. Lung cancer ranks as the fifth most common cancer in the country, with about one in 20 Australians expected to receive a diagnosis by age 85. These statistics highlight how the growing lung cancer burden is propelling demand for surgical equipment tailored to this disease.

Key Trends Shaping the Lung Cancer Surgery Equipment Industry

Leading companies in the lung cancer surgery equipment market are focusing on advancing technologies such as robotically assisted bronchoscopy. This technique improves the accuracy and safety of localizing tumors and performing biopsies, especially for hard-to-reach lung nodules, facilitating early and precise diagnosis. Robotically assisted bronchoscopy uses robotic technology to guide a flexible bronchoscope into the lungs with greater precision than manual methods. For instance, in March 2025, Johnson & Johnson announced that its MONARCH QUEST system, a sophisticated robotic bronchoscopy platform, received U.S. FDA 510(k) clearance. This system represents the latest version of the MONARCH Platform designed to enhance lung cancer diagnosis through minimally invasive procedures. It integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time intraprocedural 3D imaging that significantly improves the accuracy of targeting lung nodules in difficult locations.

Access The Complete Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Detailed Product Types and Applications in the Lung Cancer Surgery Equipment Market

This market is categorized based on product type, surgery type, application, and end user. By product type, it includes surgical instruments, access devices, imaging equipment, electrosurgical devices, biopsy devices, and patient monitoring equipment. Surgical instruments cover tools such as scalpels, forceps, retractors, scissors, and sutures. Access devices include trocars, catheters, guidewires, and introducers. Imaging equipment comprises CT scanners, MRI machines, PET scanners, X-ray systems, and ultrasound devices. Electrosurgical devices feature generators, probes, electrodes, and smoke evacuation systems. Biopsy devices are divided into needle, core, vacuum-assisted, and endoscopic biopsy tools. Patient monitoring equipment encompasses pulse oximeters, ECG monitors, respiratory monitors, blood pressure monitors, and temperature monitors. Surgery types include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. Applications span diagnosis, treatment, and aftercare or rehabilitation. End users mainly consist of hospitals, surgical clinics, ambulatory surgical centers, and research and academic institutions.

Competitive Landscape of the Lung Cancer Surgery Equipment Market

The lung cancer surgery equipment industry features several prominent companies competing strategically to expand their market presence. Major players include Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, and Ambu A S. These companies are focusing on innovation, product development, and strategic partnerships to strengthen their foothold in this competitive market.

Regional Outlook and Market Expansion Drivers for Lung Cancer Surgery Equipment

In 2025, North America emerged as the largest regional market for lung cancer surgery equipment. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period. The report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and regional growth opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model